Welch R W, Bergsten P, Butler J D, Levine M
Laboratory of Cell Biology and Genetics, National Institute of Diabetes, Digestive, and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892.
Biochem J. 1993 Sep 1;294 ( Pt 2)(Pt 2):505-10. doi: 10.1042/bj2940505.
As the initial step in the use of fibroblasts as a model system for 'in situ kinetics', ascorbic acid (vitamin C) accumulation in normal human fibroblasts was investigated for the first time. Ascorbic acid was transported into fibroblasts and accumulated against a concentration gradient up to 20-fold, as measured by h.p.l.c. with coulometric electrochemical detection. Ascorbic acid accumulation was mediated by two concentration-dependent transport activities. The first was a high-affinity activity with an apparent Km of 6 microM and an apparent Vmax. of 203 microM/h, and the second was a low-affinity activity with an apparent Km of 5 mM and an apparent Vmax. of 1.8 mM/h. Both activities were inhibited by metabolic inhibitors and inhibitors of ascorbic acid transport in human neutrophils. The low-affinity transporter could not be accounted for by diffusion. Although the high-affinity transport activity was comparable with that described for human neutrophils, the low-affinity transporter was different. These data provide the first evidence that two-component ascorbic acid transport may be a generalized mechanism for accumulation of this vitamin in humans.
作为将成纤维细胞用作“原位动力学”模型系统的第一步,首次对正常人成纤维细胞中抗坏血酸(维生素C)的积累情况进行了研究。通过采用电量分析法电化学检测的高效液相色谱法测定,抗坏血酸被转运至成纤维细胞中,并逆浓度梯度积累高达20倍。抗坏血酸的积累由两种浓度依赖性转运活性介导。第一种是高亲和力活性,其表观Km为6微摩尔,表观Vmax为203微摩尔/小时;第二种是低亲和力活性,其表观Km为5毫摩尔,表观Vmax为1.8毫摩尔/小时。两种活性均受到代谢抑制剂和人中性粒细胞中抗坏血酸转运抑制剂的抑制。低亲和力转运体不能用扩散来解释。虽然高亲和力转运活性与人中性粒细胞中描述的活性相当,但低亲和力转运体有所不同。这些数据首次证明,双组分抗坏血酸转运可能是这种维生素在人体内积累的普遍机制。